Fears are growing in the City that RSA may have to take another bite out of its dividend after the insurer has shown a blind spot for looming accidents

London-listed pharmaceuticals group says the deal will boost its rare disease unit and generate cost synergies of about $150m by 2015

Investors were warned that BT's move into sport would be costly – and the price went up with the latest rights package. But there are rewards, too

Group finds two potential problems – how Irish arm booked large losses, and how it recorded ‘earned' income, as opposed to premiums merely ‘written'

Court hearing over damages claim brought by Constantin Medien hears how Slavica obtained a court order in 2010 to recover the money

German mail and logistics group remains upbeat on full-year forecasts as it expands its parcel business to harness growth of online retailing

Poles and Hungarians are taking legal action against banks that sold them foreign exchange mortgages, saying they were offered poor financial advice

Departure comes barely a year after Bruno Pfister, who had guided group through the financial crisis, launched a three-year plan to boost profits

Coalition negotiators propose removal of exemptions that have shielded companies from the cost of moving to renewable power

Commodities traders and executives are focused on what the publicity shy family-owned group will do after its purchase of Armajaro group